Psychedelics Today PT562 – Ketamine-Assisted Therapy at Work? The Future of Employee Benefits, with Jessica Tracy
In this episode, Joe interviews Jessica Tracy: head of sales & partnerships at Enthea, a company that works with employers, unions, and employee assistance programs to be able to offer ketamine-assisted therapy (and psilocybin where it’s legal) to employees.
She talks about her path to psychedelics and how the shifts in her life led her to want to help others, finding Enthea and using her 15 years of experience in healthcare to make an immediate difference. She explains how the process works for an employee of a company Enthea works with, and the importance of evidence-based medical policy and rigorous screening to make sure people are getting the best intervention possible. One of Enthea’s largest clients is Dr. Bronner’s, who reported incredible improvements after employees used the benefit, with a 65% improvement in depression scores and an 86% improvement in PTSD.
She also discusses:
- How psychedelics bring awareness to what we need to work on
- Less-discussed treatment modalities, like electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), and stellate ganglion block (SGB)
- The inefficiency of traditional talk therapy: 50% of people only see really good benefits after 20 sessions
- The importance of viewing mental health as individualized care: What else can we offer to people who haven’t been helped by traditional methods?
- The research that she wants to see, like measures in how present or productive people are before and after experiences
and more!